<p>Cefpodoxime is indicated for the treatment of infections caused by susceptible microorganism, listed below:</p>

<ul>
	<li>Acute otitis media caused by Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenza, Moraxella catarrhalis (including beta-lactamase producing strains).</li>
	<li>Pharyngitis/tonsillitis caused by Streptococcus pyogenes.</li>
	<li>Acute maxillary sinusitis caused by Haemophilus influenzae (including beta-lactamase producing strains), Streptococcus pneumoniae and Moraxella catarrhalis.</li>
	<li>Community acquired pneumonia caused by S. pneumoniae or H. influenza (including beta-lactamase-producing strains).</li>
	<li>Acute bacterial exacerbation of chronic bronchitis caused by S. pneumoniae, H. influenzae (non-beta-lactamase-producing strains only), or M. catarrhalis.</li>
	<li>Skin and skin structure infections caused by Staphylococcus aureus, Streptococcus pyogenes.</li>
	<li>Uncomplicated urinary tract infections caused by E. coli, Klebsiella pneumoniae, Proteus mirabilis or Staphylococcus saprophyticus.</li>
	<li>Uncomplicated gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains).</li>
	<li>Rectal gonococcal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains).</li>
</ul>